Serine/threonine protein kinase 39 (STK39) gene has attracted much renewed interest since the identification of its genetic variants in susceptibility to hypertension by Wang et al. in a genome-wide association study.
1 STK39, as a putative thiazide diuretic response gene, is activated in response to hypotonic stress, leading to phosphorylation of several cation-chloride-coupled cotransporters.
2
Although genome-wide association studies have delivered dozens of bona fide associations, there is no universal consensus across all such studies on a certain or several identified variants being consistently associated with hypertension at the genome significance.
Apart from clinical heterogeneity, these studies are mainly complicated by complex genetic profiles. As recommended by Chanock et al., to provide a strong causal association, it is necessary for an effect of multiple risk loci being consistently examined in various populations. 3 In response to this request, we therefore aimed to test whether five top signals in Wang et al.'s study 1 were also susceptible loci for hypertension in Han Chinese. Thereof, four intronic polymorphisms (rs35929607, rs3754777, rs6749447, and rs12692877) were assigned in STK39 gene (2q24.3) and one intergenic polymorphism rs4977950 at chromosome 9p21.3.
The description of this study population totaling 1108 unrelated local residents of Han descent in Shanghai city was reported elsewhere. 4, 5 A total of 548 patients diagnosed with essential hypertension and 560 controls were matched for age, gender, and area. The ethics committee of Ruijin Hospital approved this study, and all participants completed written informed consent. Diagnosis of hypertension was based on the three-time means of systolic or diastolic blood pressure (SBP or DBP) X140 or 90 mm Hg, or receipt of antihypertensive medication. As recommended by Tobin et al., for individuals in antihypertensive medication, blood pressure was imputed by adding 15 and 10 mm Hg for SBP and DBP, respectively. 6 Cases of secondary hypertension were excluded from the study through extensive clinical and biochemical evaluations.
Genomic DNA was extracted from white blood cells using a standard phenol-chloroform method, and genotyping was performed using the PCR-ligase detection reactions (LDR) method. 7 The primers for amplification and lengths of PCR products were available upon request. The PCR reactions were conducted in an ABI 9600 (Applied Biosystems, Foster City, CA, USA) and the fluorescent products of LDR were differentiated using ABI sequencer 377 (Applied Biosystems).
Simple statistical analyses were conducted using R software (version 2.10, available at the website http://www.cran.r-project.org/). The w 2 -test was used to assess the goodness-of-fit between the observed allele frequencies and the expected counterparts by Hardy-Weinberg equilibrium. The haplo.em program was used to estimate the haplotype frequencies between cases and controls. The haplo. glm program was employed to calculate adjusted odds ratios and 95% confidence intervals for each haplotype. Only the haplotypes with frequencies 41% were considered for the haplotype analyses. Furthermore, the haplotype score was used to model an individual's phenotype as a function of each inferred haplotype, weighted by their estimated probability, to account for haplotype ambiguity. The haplo.em and haplo.glm programs were implemented in the package Haplo.stats (version 1.4.0, available at the website http://mayoresearch.mayo. edu/mayo/research/schaid_lab/software.cfm), which was developed by the R software. Two-tailed P of less than 0.05 was accepted as statistical significance.
Baseline characteristics of the study population were the same as that of our recent report. 3 Genotype distributions and allele frequencies of five studied polymorphisms between cases and controls are shown in the Supplementary Table. Overall, there was no statistical significance for all genotype/allele comparisons based on the w 2 -test (all P40.05). Moreover, the genotype distributions in control group satisfied Hardy-Weinberg equilibrium for all polymorphisms (P40.05). Furthermore, we compared adjusted SBP and DBP across the three genotypes of each polymorphism in both cases and controls, and no significant results were yielded (data not shown).
As four of five studied polymorphisms were in STK39 gene, we thus constructed haplotype structures, calculated their prediction for hypertension after considering covariates of interest, and assessed their association with adjusted SBP and DBP in both groups (Table 1) . After taking haplotype T-A-C-C (alleles in order of rs35929607, rs3754777, rs6749447, and rs12692877) as a reference, we observed marginal association of haplotype G-G-C-C with hypertension with a 39% reduced risk (95% confidence interval: 0.38-0.98; P ¼ 0.041) when adjusting for age, gender, and body mass index, and we had sufficient power to detect the effect of haplotype G-G-C-C (power ¼ 91.4% by Power and Sample Size Calculations software version 3.0, available at the website http://biostat.mc. vanderbilt.edu/wiki/Main/PowerSampleSize). There was no significant prediction for other haplotypes. Furthermore, we modelled the haplotypes of four polymorphisms in STK39 gene with the adjusted SBP or DBP as the dependant variable and age, gender and body mass index as confounding factors, and interestingly found that the aforementioned significant haplotype G-G-C-C was negatively associated with adjusted SBP (haplotype score: À2.52; P ¼ 0.033), which was in line with its haplotype risk prediction in magnitude and direction.
Similar to the single-locus results of the present study, a recent report by Cunnington et al. also failed to provide any evidence for association of four top signals in Wang et al.'s with blood pressure in a British Caucasian cohort, 8 leading to conjecture that none of the individual polymorphisms was in strong linkage disequilibrium with the causal mutation(s). However, we cannot exclude the possible involvement of STK39 gene and its encoded protein in the pathogenesis of hypertension, as both in vitro (transient transfection experiments using reporter constructs) 1 and in vivo (cis-acting experiment of allelic expression) 8 functional studies have demonstrated positive associations. It is thus reasonable to speculate that if involved, the net effect of STK39 on hypertension or blood pressure might be small or moderate, or its significant effect was partly offset or antagonised by other cellular regulators or mediators. Moreover, significant associations were found only in the USA Caucasians but not for Chinese and British Caucasians, suggesting a possible role of ethnic differences in genetic backgrounds and the environment they lived in.
On the other hand, the possibility of synergistic effects between top signals examined in STK39 gene may hold water, which was exemplified by our haplotype analyses, which can provide more information upon the effect of genetic interaction. 9 Of particular, a haplotype harbouring G-G-C-C alleles conferred a marginally protective effect for hypertension and a negative influence on the adjusted SBP in Han Chinese. This positive association with SBP rather than DBP is not surprising, as most epidemiologists share the point of view that SBP increases with age until the eighth decade of life, whereas DBP rises only until 50 years of age, after which it either becomes constant or even decreases slightly. 10 Factually, most of the hypertensive patients in this study population aged above 45 years old, so the contributing haplotype inferred might be associated with systolic essential hypertension in Han Chinese. However, because of the complex nature of hypertension, the jury must refrain from drawing a firm conclusion until a large, wellperformed study in Chinese confirms or refutes our findings.
In sum, we extend a step beyond previous evidence showing that the STK39 gene might not be a major contributing hypertension-susceptibility gene in Han Chinese; its genetic variation might had a synergistic effect. Additional studies examining gene-gene or gene-environment interactions, as well as studies seeking to provide biological or clinical validations of our findings, are warranted. Alleles were in order of rs35929607 (T/G), rs3754777 (A/G), rs6749447 (C/A), and rs12692877 (G/C). b Prediction of hypertension was adjusted for age, gender, and body mass index.
